Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002181 · ClinicalTrials.gov registry record · NA
Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS
A NA study, sponsored by Gilead Sciences.
- Completed
- Registry status
- NA
- Development phase
NCT00002181: Completed NA study, sponsored by Gilead Sciences.
NCT00002181 is a NA study that has completed, run by Gilead Sciences. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002181, a NA study, has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to see if cidofovir gel (Forvade) is safe and effective in treating herpes simplex in patients with AIDS who do not respond to acyclovir.
Interventions
- DRUG Cidofovir
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002181 record still lists
NCT00002181 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Cidofovir is the first listed.
NCT00002181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002181 about?
NCT00002181 is a clinical study titled "Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS". The purpose of this study is to see if cidofovir gel (Forvade) is safe and effective in treating herpes simplex in patients with AIDS who do not respond to acyclovir.
What is the current status of trial NCT00002181?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002181?
The interventions under investigation include: Cidofovir (DRUG).
Who is sponsoring clinical trial NCT00002181?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.